AstraZeneca

From Wikispooks
Revision as of 11:09, 21 May 2020 by Patrick Haseldine (talk | contribs) (Importing from WP and expanding)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Group.png AstraZeneca (AZN)  Rdf-entity.pngRdf-icon.png
AstraZeneca.jpg
Member ofWEF/Strategic Partners, Wallenberg Sphere
SubpageAstraZeneca/Chairman

AstraZeneca plc is a British-Swedish multinational Big Pharma company.

In 2013, AstraZeneca moved its headquarters to Cambridge, United Kingdom, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA (location of MedImmune) for work on biopharmaceuticals; and Mölndal (near Gothenburg) in Sweden, for research on traditional chemical drugs.[1]

History

AstraZeneca was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993).[2][3] Since the merger AZN has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014).

COVID-19

In March 2020, AstraZeneca announced that it would be donating personal protective equipment, including 9 million face masks, to help support various international health organisations mitigating the COVID-19 pandemic.[4]

Cambridge testing

In April, CEO Pascal Soriot reported that the company was working with GlaxoSmithKline and the University of Cambridge to develop a new laboratory capable of conducting 30,000 COVID-19 tests per day.[5]

Oxford vaccine

On 21 May 2020, AZN announced it had received support of more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) for the development, production and delivery of a potential vaccine to battle the COVID-19 infection, starting in the fall.[6] AZN said it has the capacity to manufacture 1 billion doses of the University of Oxford’s potential vaccine through 2020 and 2021 and it has already secured the first agreements for at least 400 million doses of the vaccine.[7]

AZN also announced its licence agreement had been finalised with Oxford University for the recombinant adenovirus vaccine. The licensing of the vaccine, formerly ChAdOx1 nCoV-19 and now known as AZD1222, follows the recent global development and distribution agreement with the University’s Jenner Institute and the Oxford Vaccine Group. AstraZeneca has also agreed to support the establishment of a joint research centre at Oxford University for pandemic preparedness research. A Phase I/II clinical trial of AZD1222 began last month to assess safety, immunogenicity and efficacy in over 1,000 healthy volunteers aged 18 to 55 years across several trial centres in southern England. Data from the trial is expected shortly which, if positive, would lead to late-stage trials in a number of countries. AstraZeneca recognises that the vaccine may not work but is committed to progressing the clinical program with speed and scaling up manufacturing at risk.[8]

 

Known member

1 of the 13 of the members already have pages here:

MemberDescription
Marcus Wallenberg (born 1956)Swedish deep state operative, ex-Bilderberg Steering Committee

 

Related Document

TitleTypePublication dateAuthor(s)Description
Document:MPs given guide to spotting conspiracy theoriesArticle10 May 2024Jennifer McKiernan
Marianna Spring
Penny Mordaunt has commissioned a booklet for MPs on conspiracy theories.
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.


References

Wikipedia.png This page imported content from Wikipedia on 21 May 2020.
Wikipedia is not affiliated with Wikispooks.   Original page source here